Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...

Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...

The stock's fall snapped a four-day winning streak.

Highlights,Charles Schwab Investment Management increased its holdings in Henry Schein, reaching close to 1% ...

Learn more about whether Henry Schein, Inc. or LifeStance Health Group, Inc. is a better investment based on AAII's A+ ...

Shares of Henry Schein Inc. HSIC rose 2.23% to $74.59 Friday, on what proved to be an all-around favorable trading session ...

Rating, from 69 to 74. Please watch the video at Investors.com - How To Find The Best IPO Stocks IBD's unique rating tracks ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Henry Schein (HSIC – Research Report) today and set a price target of ...

Meeting to be held on March 10 at 11 am hosted by Oppenheimer. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Detailed price information for Dentsply Sirona Inc (XRAY-Q) from The Globe and Mail including charting and trades.

Henry Schein has acquired R. Weinstein, Inc., a provider of vaccines, medical-surgical products and equipment to Hawaii-based health care facilities and practitioners.

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair ...